References
- Bo XW, Xu HX, Wang D, et al. (2016). Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol 89:20160379.
- Lee MW, Rhim H, Cha DI, et al. (2013). Planning US for percutaneous radiofrequency ablation of small hepatocellular carcinomas (1–3 cm): value of fusion imaging with conventional US and CT/MR images. J Vasc Interv Radiol 24:958–65.
- Song KD, Lee MW, Rhim H, et al. (2013). Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. AJR Am J Roentgenol 201:1141–7.
- Mauri G, Cova L, De Beni S, et al. (2015). Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol 38:143–51.
- Liu FY, Yu XL, Liang P, et al. (2012). Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol 81:1455–9.
- Toshikuni N, Tsutsumi M, Takuma Y, Arisawa T. (2014). Real-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinoma. J Ultrasound Med 33:2005–10.
- Yu XL, Liu FY, Liang P, et al. (2011). Microwave ablation assisted by a computerised tomography-ultrasonography fusion imaging system for liver lesions: an ex vivo experimental study. Int J Hyperthermia 27:172–9.
- Makino Y, Imai Y, Igura T, et al. (2013). Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma. Dig Dis 31:485–9.
- Lee JY, Choi BI, Chung YE, et al. (2012). Clinical value of CT/MR-US fusion imaging for radiofrequency ablation of hepatic nodules. Eur J Radiol 81:2281–9.
- Zhong-Zhen S, Kai L, Rong-Qin Z, et al. (2012). A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma. Ultraschall Med 33:E250–5.
- Li K, Su ZZ, Xu EJ, et al. (2016). Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma. BMC Cancer 16:277.
- Claudon M, Dietrich CF, Choi BI, et al. (2013). Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound. Med Biol 39:187–210.
- Su ZZ, Li K, Xu EJ, et al. (2015). A clinical validation study for the feasibility and reliability of three-dimensional ultrasound-ultrasound automatic image registration. Int J Hyperthermia 31:875–82.
- Hiraoka A, Hirooka M, Koizumi Y, et al. (2010). Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system. Oncol Rep 23:493–7.
- Bruix J, Sherman M. American Association for the Study of Liver Diseases (2011). Management of hepatocellular carcinoma: an update. Hepatology 53:1020–2.
- Liu M, Huang GL, Xu M, et al. (2017). Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacy. Int J Hyperthermia 33:1–11.
- Ahmed M, Solbiati L, Brace CL, et al. (2014). Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology 273:241–60.
- Toshikuni N, Shiroeda H, Ozaki K, et al. (2013). Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma. Radiol Oncol 47:224–9.
- Minami Y, Minami T, Chishina H, et al. (2016). US-US fusion imaging in radiofrequency ablation for liver metastases. Dig Dis 34:687–91.
- Lekht I, Gulati M, Nayyar M, et al. (2016). Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone. Abdom Radiol (NY) 41:1511–21.
- Meloni MF, Andreano A, Franza E, et al. (2012). Contrast enhanced ultrasound: should it play a role in immediate evaluation of liver tumors following thermal ablation? Eur J Radiol 81:e897–902.
- Ierardi AM, Giorlando F, Piacentino F, et al. (2017). Factors predicting outcomes of microwave ablation of small hepatocellular carcinoma. Radiol Med 122:81–7.
- Kawasaki T, Hata KY, Kinoshita D, et al. (2016). Radiofrequency ablation guided by contrast-enhanced sonography versus B-mode sonography for hepatocellular carcinoma after transcatheter arterial chemoembolization. Dig Dis 34:692–5.
- Ayav A, Germain A, Marchal F, et al. (2010). Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200:435–9.
- Wang T, Lu XJ, Chi JC, et al. (2016). Microwave ablation of hepatocellular carcinoma as first-line treatment: long term outcomes and prognostic factors in 221 patients. Sci Rep 6:32728.
- Zhai H, Liang P, Yu XL, et al. (2015). Microwave ablation in treating intrahepatic recurrence of hepatocellular carcinoma after liver transplantation: an analysis of 11 cases. Int J Hyperthermia 31:863–8.
- Zhang D, Liang P, Yu X, et al. (2013). The value of artificial pleural effusion for percutaneous microwave ablation of liver tumour in the hepatic dome: a retrospective case-control study. Int J Hyperthermia 29:663–70.
- Park HJ, Lee MW, Rhim H, et al. (2015). Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography. Clin Radiol 70:387–94.